NextCure, Inc.
NASDAQ:NXTC
1.42 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0 | 22.378 | 6.347 | 0 | 0 |
| Kosten van de omzet
| 3.684 | 4.48 | 4.3 | 0.047 | 0.034 | 1.677 | 0.582 |
| Brutowinst
| -3.684 | -4.48 | -4.3 | 22.331 | 6.313 | -1.677 | -0.582 |
| Brutowinstmarge
| 0 | 0 | 0 | 0.998 | 0.995 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 47.931 | 54.199 | 50.192 | 46.554 | 34.216 | 19.787 | 12.954 |
| Algemene en administratieve kosten
| 19.706 | 21.71 | 20.573 | 17.049 | 9.613 | 3.409 | 2.595 |
| Verkoop- en marketingkosten
| -3.684 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 16.022 | 21.71 | 20.573 | 17.049 | 9.613 | 3.409 | 2.595 |
| Overige kosten
| 0 | 1.176 | 1.376 | 4.622 | 3.745 | 0.397 | 0.08 |
| Bedrijfskosten
| 63.953 | 75.909 | 70.765 | 63.603 | 43.829 | 23.196 | 15.549 |
| Bedrijfsresultaat
| -67.637 | -75.909 | -70.765 | -41.225 | -37.482 | -23.196 | -15.549 |
| Bedrijfsresultaat ratio
| 0 | 0 | 0 | -1.842 | -5.905 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 4.914 | 1.176 | 1.376 | 4.622 | 3.745 | 0.397 | 0.08 |
| Inkomen voor belasting
| -62.723 | -74.733 | -69.389 | -36.603 | -33.737 | -22.799 | -15.469 |
| Inkomen voor belasting ratio
| 0 | 0 | 0 | -1.636 | -5.315 | 0 | 0 |
| Belastingkosten
| 0 | -5.3 | 6.959 | -3.413 | 2.516 | 0.397 | 0 |
| Nettowinst
| -62.723 | -69.433 | -69.389 | -33.19 | -33.737 | -22.799 | -15.469 |
| Nettowinstmarge
| 0 | 0 | 0 | -1.483 | -5.315 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -2.25 | -2.5 | -2.51 | -1.21 | -2.15 | -2.27 | -1.54 |
| Verwaterde WPA
| -2.25 | -2.5 | -2.51 | -1.21 | -2.15 | -2.27 | -1.54 |
| EBITDA
| -63.953 | -75.909 | -63.569 | -41.225 | -34.794 | -21.519 | -14.967 |
| EBITDA ratio
| 0 | 0 | 0 | -1.842 | -5.482 | 0 | 0 |